Stand up to Cancer: MAGENTA (Making Genetic Testing Accessible)
NCT02993068 · Status: SUSPENDED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 5200
Last updated 2026-02-19
Summary
This randomized clinical trial studies how well online genetics educational video with or without pre- and/or post-telephone genetics counseling works in assessing cancer-risk distress in patients with triple negative breast cancer. Online genetic education and telephone genetic counseling may help the doctors learn the stress a person feels about their risk of cancer.
Conditions
- BARD1 Gene Mutation
- BRCA1 Gene Mutation
- BRCA2 Gene Mutation
- BRIP1 Gene Mutation
- Estrogen Receptor Negative
- HER2/Neu Negative
- MLH1 Gene Mutation
- MSH2 Gene Mutation
- MSH6 Gene Mutation
- PALB2 Gene Mutation
- PMS2 Gene Mutation
- Progesterone Receptor Negative
- RAD51C Gene Mutation
- RAD51D Gene Mutation
- Triple-Negative Breast Carcinoma
Interventions
- OTHER
-
Questionnaire Administration
Ancillary studies
- OTHER
-
Educational Intervention
Watch genetic testing online educational video
- OTHER
-
Genetic Counseling
Receive post-telephone genetic counseling
- OTHER
-
Genetic Counseling
Receive pre-telephone genetic counseling
- OTHER
-
Laboratory Biomarker Analysis
Correlative studies
Sponsors & Collaborators
-
National Cancer Institute (NCI)
collaborator NIH -
M.D. Anderson Cancer Center
lead OTHER
Principal Investigators
-
Roni Wilke · M.D. Anderson Cancer Center
Study Design
- Allocation
- RANDOMIZED
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 30 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-04-18
- Primary Completion
- 2026-04-18
- Completion
- 2026-04-18
Countries
- United States
Study Locations
More Related Trials
-
Biomarkers in Predicting Response to Tamoxifen and Letrozole in Postmenopausal Women With Primary Breast Cancer Treated on Clinical Trial CAN-NCIC-MA17
NCT00897065 ·Status: UNKNOWN
-
Decision Support Following Genetic Testing for Breast-Ovarian Cancer Susceptibility
NCT02133703 ·Status: COMPLETED ·Phase: NA
-
Outcomes of Education and Counseling for BRCA1 Testing
NCT00001468 ·Status: COMPLETED
-
Digital Delivery of Information About Genetic Testing for Breast Cancer
NCT04842799 ·Status: COMPLETED ·Phase: NA
-
Hypofractionated Radiotherapy Before or After Breast Surgery for Treatment of Patients With Non-Metastatic Breast Cancer
NCT06635980 ·Status: RECRUITING ·Phase: PHASE2
-
Genetic Testing for Breast, Ovarian, Pancreatic, and Prostate Cancers
NCT04330716 ·Status: COMPLETED ·Phase: NA
-
Identification of Novel Genetic Factors That Contribute to Risk for Breast Cancer
NCT00276120 ·Status: COMPLETED
-
Genetic Counseling Patient Preference Intervention Versus Conventional Genetic Counseling for Women at Elevated Risk for Breast Cancer
NCT05325151 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
4R for Guideline Indicated BRCA Testing of Breast Center Patients
NCT01320540 ·Status: COMPLETED
-
Comprehensive Genetic Assessment, Risk and Education in a Mammography Pilot
NCT04002986 ·Status: COMPLETED ·Phase: NA
-
The Communication of Genetic Risk to Adolescent Daughters of Women With Breast Cancer
NCT00588705 ·Status: COMPLETED
-
Breast Imaging Studies in Women at High Genetic Risk of Breast Cancer: Menstrual Cycle Study
NCT00006425 ·Status: COMPLETED
-
Responses to Genetic Risk Modifier Testing Among Women With Pathogenic Variants in Breast Cancer Predisposition Genes
NCT03396341 ·Status: RECRUITING
-
Comprehensive Screening for Women at High Genetic Risk for Developing Breast Cancer
NCT00255060 ·Status: COMPLETED
-
Cancer Prevention in Women With a BRCA Mutation
NCT02225015 ·Status: UNKNOWN ·Phase: PHASE1
-
Counseling Interventions for BRCA 1/2 Cancer Susceptibility Testing
NCT00165152 ·Status: COMPLETED ·Phase: NA
-
A Patient Reminder and Self-Referral Via Online Patient Portals and Text Messaging to Improve Adherence to Breast Cancer Screening
NCT05526872 ·Status: COMPLETED ·Phase: NA
-
Development of a Genetic Counseling Patient Preference Intervention for Women at Elevated Risk for Breast Cancer
NCT05158452 ·Status: COMPLETED
-
A Study of the Communication of Genetic Test Results By Telephone: A Multi-Center Study
NCT01736345 ·Status: COMPLETED
-
Genetic Testing for All Breast Cancer Patients (GET FACTS)
NCT04245176 ·Status: COMPLETED ·Phase: NA
-
Studying Tissue Samples From Women With Breast Cancer Who Were Treated on Clinical Trial NCCTG-N9831
NCT00898898 ·Status: COMPLETED
-
Studying Biomarkers in Nipple Fluid, Urine, and Blood Samples From Women With Newly Diagnosed Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer and in Women at Risk of Developing Breast Cancer
NCT00897208 ·Status: COMPLETED
-
Serum Biomarkers to Characterize the Effects of Therapy on Ovarian Reserve in Premenopausal Women With Early-stage Breast Cancer or BRCA Mutations
NCT00823654 ·Status: RECRUITING
-
Use of an Ultra-rapid BRCA1/2 Status Screening Test in Diagnostic and Theranostic Indication: Performance and Interest for Patients and Practitioners
NCT06111417 ·Status: RECRUITING
-
Identification and Referral of Women at Risk for Hereditary Breast/Ovarian Cancer
NCT02786147 ·Status: COMPLETED